173 related articles for article (PubMed ID: 34865079)
21. Radiomics analysis of magnetic resonance imaging improves diagnostic performance of lymph node metastasis in patients with cervical cancer.
Wu Q; Wang S; Chen X; Wang Y; Dong L; Liu Z; Tian J; Wang M
Radiother Oncol; 2019 Sep; 138():141-148. PubMed ID: 31252296
[TBL] [Abstract][Full Text] [Related]
22. Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer.
Fang J; Zhang B; Wang S; Jin Y; Wang F; Ding Y; Chen Q; Chen L; Li Y; Li M; Chen Z; Liu L; Liu Z; Tian J; Zhang S
Theranostics; 2020; 10(5):2284-2292. PubMed ID: 32089742
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of MRI-based radiomics features for predicting lymph node metastases and VEGF expression in cervical cancer.
Deng X; Liu M; Sun J; Li M; Liu D; Li L; Fang J; Wang X; Zhang J
Eur J Radiol; 2021 Jan; 134():109429. PubMed ID: 33290975
[TBL] [Abstract][Full Text] [Related]
24. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
[TBL] [Abstract][Full Text] [Related]
25. Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.
Autorino R; Gui B; Panza G; Boldrini L; Cusumano D; Russo L; Nardangeli A; Persiani S; Campitelli M; Ferrandina G; Macchia G; Valentini V; Gambacorta MA; Manfredi R
Radiol Med; 2022 May; 127(5):498-506. PubMed ID: 35325372
[TBL] [Abstract][Full Text] [Related]
26. External validation of a combined PET and MRI radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapy.
Lucia F; Visvikis D; Vallières M; Desseroit MC; Miranda O; Robin P; Bonaffini PA; Alfieri J; Masson I; Mervoyer A; Reinhold C; Pradier O; Hatt M; Schick U
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):864-877. PubMed ID: 30535746
[TBL] [Abstract][Full Text] [Related]
27. Development of a Deep Learning Model to Identify Lymph Node Metastasis on Magnetic Resonance Imaging in Patients With Cervical Cancer.
Wu Q; Wang S; Zhang S; Wang M; Ding Y; Fang J; Wu Q; Qian W; Liu Z; Sun K; Jin Y; Ma H; Tian J
JAMA Netw Open; 2020 Jul; 3(7):e2011625. PubMed ID: 32706384
[TBL] [Abstract][Full Text] [Related]
28. Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01.
Lee SW; Lee SH; Kim J; Kim YS; Yoon MS; Jeong S; Kim JH; Lee J; Eom KY; Jeong BK; Sung SY; Lee SJ; Lee JH
Gynecol Oncol; 2017 Nov; 147(2):334-339. PubMed ID: 28935271
[TBL] [Abstract][Full Text] [Related]
29. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
[TBL] [Abstract][Full Text] [Related]
30. Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors.
Zheng X; Guo W; Dong J; Qian L
Magn Reson Imaging; 2020 Oct; 72():159-166. PubMed ID: 32621877
[TBL] [Abstract][Full Text] [Related]
31. Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images.
Erbay G; Onal C; Karadeli E; Guler OC; Arica S; Koc Z
Acta Radiol; 2017 Apr; 58(4):481-488. PubMed ID: 27445314
[TBL] [Abstract][Full Text] [Related]
32. MRI-based radiomics analysis to evaluate the clinicopathological characteristics of cervical carcinoma: a multicenter study.
Liu Y; Song T; Dong TF; Zhang W; Wen G
Acta Radiol; 2023 Jan; 64(1):395-403. PubMed ID: 34918963
[TBL] [Abstract][Full Text] [Related]
33. Delta radiomics analysis for prediction of intermediary- and high-risk factors for patients with locally advanced cervical cancer receiving neoadjuvant therapy.
Wu RR; Zhou YM; Xie XY; Chen JY; Quan KR; Wei YT; Xia XY; Chen WJ
Sci Rep; 2023 Nov; 13(1):19409. PubMed ID: 37938596
[TBL] [Abstract][Full Text] [Related]
34. Patient survival prediction in locally advanced cervical squamous cell carcinoma using MRI-based radiomics: retrospective cohort study.
Bseiso A; Saqib M; Saigol MS; Rehman A; Sare A; Yagoub AE; Mumtaz H
Ann Med Surg (Lond); 2023 Nov; 85(11):5328-5336. PubMed ID: 37915655
[TBL] [Abstract][Full Text] [Related]
35. Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy.
Onal C; Erbay G; Guler OC
J Magn Reson Imaging; 2016 Oct; 44(4):1010-9. PubMed ID: 26919800
[TBL] [Abstract][Full Text] [Related]
36. Pre-treatment prediction of early response to chemoradiotherapy by quantitative analysis of baseline staging FDG-PET/CT and MRI in locally advanced cervical cancer.
Min LA; Ackermans LL; Nowee ME; Griethuysen JJV; Roberti S; Maas M; Vogel WV; Beets-Tan RG; Lambregts DM
Acta Radiol; 2021 Jul; 62(7):940-948. PubMed ID: 32722967
[TBL] [Abstract][Full Text] [Related]
37. Texture Analysis of Apparent Diffusion Coefficient Maps in Cervical Carcinoma: Correlation with Histopathologic Findings and Prognosis.
Yamada I; Oshima N; Miyasaka N; Wakana K; Wakabayashi A; Sakamoto J; Saida Y; Tateishi U; Kobayashi D
Radiol Imaging Cancer; 2020 May; 2(3):e190085. PubMed ID: 33778713
[TBL] [Abstract][Full Text] [Related]
38. Combined dynamic contrast enhanced MRI parameter with clinical factors predict the survival of concurrent chemo-radiotherapy in patients with 2018 FIGO IIICr stage cervical cancer.
Qin F; Pang H; Ma J; Zhao M; Jiang X; Tong R; Yu T; Luo Y; Dong Y
Eur J Radiol; 2021 Aug; 141():109787. PubMed ID: 34051683
[TBL] [Abstract][Full Text] [Related]
39. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
Ma R; Zhang H; Zou L; Qu Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
[TBL] [Abstract][Full Text] [Related]
40. Radiomics Analysis of Multiparametric MRI Evaluates the Pathological Features of Cervical Squamous Cell Carcinoma.
Wu Q; Shi D; Dou S; Shi L; Liu M; Dong L; Chang X; Wang M
J Magn Reson Imaging; 2019 Apr; 49(4):1141-1148. PubMed ID: 30230114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
